Amber L. Delmas

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index905citations26works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(15), RNA modifications and cancer(6), Cancer-related gene regulation(6), Inflammatory Bowel Disease(4), Histone Deacetylase Inhibitors Research(4)

Publications26 total

Data from DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
2023Open Access
Supplementary Table 1 from DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
2023Open Access
Supplementary Figures 1-8, Methods from DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
2023Open Access
Data from DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
2023Open Access
Supplementary Figures 1-8, Methods from DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
2023Open Access
Supplementary Table 1 from DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
2023Open Access
Supplementary Table 2 from DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
2023Open Access
Supplementary Table 2 from DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
2023Open Access
Development of a putative Zn2+-chelating but highly selective MMP-13 inhibitor
Bioorganic & Medicinal Chemistry Letters·2022· 10 citedOpen Access
Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy
Inflammatory Bowel Diseases·2022· 26 citedOpen Access
CHARACTERIZATION OF IMMUNE PHENOTYPES AS PREDICTIVE BIOMARKERS FOR RESPONSE TO THE α4β7 INTEGRIN BLOCKER, VEDOLIZUMAB
Gastroenterology·2021
CHARACTERIZATION OF IMMUNE PHENOTYPES AS PREDICTIVE BIOMARKERS FOR RESPONSE TO THE α4β7 INTEGRIN BLOCKER, VEDOLIZUMAB
Inflammatory Bowel Diseases·2021Open Access
The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids
Immunity·2020· 8 citedOpen Access
The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids
Immunity·2017· 100 citedOpen Access
The xenobiotic transporter Mdr1 permits T cell adaptation to mucosa-associated bile acids in the ileum
The Journal of Immunology·2017
Informatics-Based Discovery of Disease-Associated Immune Profiles
PLoS ONE·2016· 2 citedOpen Access
Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock
Annals of Surgery·2016· 258 citedOpen Access
Quantitative DNA Methylation Analysis of Candidate Genes in Cervical Cancer
PLoS ONE·2015· 55 citedOpen Access
WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix
Carcinogenesis·2011· 30 citedOpen Access
Simultaneous Single‐Molecule Mapping of Protein‐DNA Interactions and DNA Methylation by MAPit
Current Protocols in Molecular Biology·2011· 20 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

C. Robert Fields(11), Keith D. Robertson(11), Bilian Jin(10), Bing Yao(10), Jian‐Liang Li(9), Chen Liu(9), Mark S. Sundrud(8), Gogce Crynen(5), María T. Abreu(5), Angelos Oikonomopoulos(4), Precious Lacey(4), Daniël W. Hommes(4), Kevin D. Brown(4), Wei Cao(3), Hisako Kayama(3), Mei Lan Chen(3), Amy Sun(3), Sang Yong Kim(3), Erumbi S. Rangarajan(3), Kelly McKevitt(3)